AAPL   322.96 (-0.66%)
MSFT   183.33 (-1.17%)
FB   227.11 (-1.33%)
GOOGL   1,418.64 (-1.43%)
NVDA   351.81 (+0.29%)
BABA   219.25 (+0.11%)
MU   51.15 (+3.96%)
TSLA   878.72 (-0.48%)
AMD   52.51 (-0.42%)
T   31.51 (+0.00%)
F   6.35 (+2.58%)
DIS   123.10 (+0.75%)
BAC   26.32 (+1.27%)
BA   184.83 (+6.73%)
AAPL   322.96 (-0.66%)
MSFT   183.33 (-1.17%)
FB   227.11 (-1.33%)
GOOGL   1,418.64 (-1.43%)
NVDA   351.81 (+0.29%)
BABA   219.25 (+0.11%)
MU   51.15 (+3.96%)
TSLA   878.72 (-0.48%)
AMD   52.51 (-0.42%)
T   31.51 (+0.00%)
F   6.35 (+2.58%)
DIS   123.10 (+0.75%)
BAC   26.32 (+1.27%)
BA   184.83 (+6.73%)
AAPL   322.96 (-0.66%)
MSFT   183.33 (-1.17%)
FB   227.11 (-1.33%)
GOOGL   1,418.64 (-1.43%)
NVDA   351.81 (+0.29%)
BABA   219.25 (+0.11%)
MU   51.15 (+3.96%)
TSLA   878.72 (-0.48%)
AMD   52.51 (-0.42%)
T   31.51 (+0.00%)
F   6.35 (+2.58%)
DIS   123.10 (+0.75%)
BAC   26.32 (+1.27%)
BA   184.83 (+6.73%)
AAPL   322.96 (-0.66%)
MSFT   183.33 (-1.17%)
FB   227.11 (-1.33%)
GOOGL   1,418.64 (-1.43%)
NVDA   351.81 (+0.29%)
BABA   219.25 (+0.11%)
MU   51.15 (+3.96%)
TSLA   878.72 (-0.48%)
AMD   52.51 (-0.42%)
T   31.51 (+0.00%)
F   6.35 (+2.58%)
DIS   123.10 (+0.75%)
BAC   26.32 (+1.27%)
BA   184.83 (+6.73%)
Log in

NASDAQ:NVCNNeovasc Stock Price, Forecast & News

$3.18
-0.11 (-3.34 %)
(As of 06/4/2020 01:39 PM ET)
Add
Compare
Today's Range
$3.16
Now: $3.18
$3.30
50-Day Range
$1.88
MA: $2.59
$3.21
52-Week Range
$1.24
Now: $3.18
$8.65
Volume4,248 shs
Average Volume128,726 shs
Market Capitalization$37.56 million
P/E RatioN/A
Dividend YieldN/A
Beta2.75
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch tissue products. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
Read More
Neovasc logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.26 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NVCN
CUSIPN/A
Phone604-248-4138

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.09 million
Book Value($1.46) per share

Profitability

Net Income$-35,130,000.00
Net Margins-1,501.37%

Miscellaneous

Employees98
Market Cap$37.56 million
Next Earnings Date8/5/2020 (Estimated)
OptionableNot Optionable

Receive NVCN News and Ratings via Email

Sign-up to receive the latest news and ratings for NVCN and its competitors with MarketBeat's FREE daily newsletter.

Neovasc (NASDAQ:NVCN) Frequently Asked Questions

How has Neovasc's stock been impacted by COVID-19 (Coronavirus)?

Neovasc's stock was trading at $2.21 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NVCN stock has increased by 43.9% and is now trading at $3.18. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Neovasc?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neovasc in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Neovasc.

When is Neovasc's next earnings date?

Neovasc is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Neovasc.

How were Neovasc's earnings last quarter?

Neovasc Inc (NASDAQ:NVCN) issued its quarterly earnings results on Thursday, May, 7th. The medical equipment provider reported ($0.38) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.55) by $0.17. The medical equipment provider had revenue of $0.53 million for the quarter, compared to analyst estimates of $0.60 million. View Neovasc's earnings history.

When did Neovasc's stock split? How did Neovasc's stock split work?

Shares of Neovasc reverse split before market open on Friday, September 21st 2018. The 1-100 reverse split was announced on Tuesday, September 11th 2018. The number of shares owned by shareholders was adjusted after the market closes on Thursday, September 20th 2018. An investor that had 100 shares of Neovasc stock prior to the reverse split would have 1 shares after the split.

What price target have analysts set for NVCN?

3 Wall Street analysts have issued 12 month target prices for Neovasc's stock. Their forecasts range from $3.00 to $15.00. On average, they anticipate Neovasc's share price to reach $7.67 in the next year. This suggests a possible upside of 141.1% from the stock's current price. View analysts' price targets for Neovasc.

Has Neovasc been receiving favorable news coverage?

Media coverage about NVCN stock has trended somewhat negative on Thursday, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Neovasc earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave news articles about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days. View the latest news aboutNeovasc.

Are investors shorting Neovasc?

Neovasc saw a increase in short interest in May. As of May 15th, there was short interest totaling 244,800 shares, an increase of 18.6% from the April 30th total of 206,400 shares. Based on an average trading volume of 216,200 shares, the short-interest ratio is presently 1.1 days. Approximately 2.4% of the shares of the stock are short sold. View Neovasc's Current Options Chain.

Who are some of Neovasc's key competitors?

What other stocks do shareholders of Neovasc own?

Who are Neovasc's key executives?

Neovasc's management team includes the following people:
  • Mr. Fredericus A. Colen, Pres & CEO (Age 66)
  • Mr. Christopher Clark B.A., C.A., BA (Honours), PgD, CA, CFO & Corp. Sec. (Age 47)

What is Neovasc's stock symbol?

Neovasc trades on the NASDAQ under the ticker symbol "NVCN."

Who are Neovasc's major shareholders?

Neovasc's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Capital World Investors (5.78%), Magnetar Financial LLC (4.28%), Morgan Stanley (0.57%) and Two Sigma Advisers LP (0.35%).

Which institutional investors are selling Neovasc stock?

NVCN stock was sold by a variety of institutional investors in the last quarter, including Magnetar Financial LLC.

Which institutional investors are buying Neovasc stock?

NVCN stock was purchased by a variety of institutional investors in the last quarter, including Capital World Investors, Morgan Stanley, and Two Sigma Advisers LP.

How do I buy shares of Neovasc?

Shares of NVCN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Neovasc's stock price today?

One share of NVCN stock can currently be purchased for approximately $3.18.

How big of a company is Neovasc?

Neovasc has a market capitalization of $37.56 million and generates $2.09 million in revenue each year. The medical equipment provider earns $-35,130,000.00 in net income (profit) each year or ($5.05) on an earnings per share basis. Neovasc employs 98 workers across the globe.

What is Neovasc's official website?

The official website for Neovasc is www.neovasc.com.

How can I contact Neovasc?

Neovasc's mailing address is Suite 5138 - 13562 Maycrest Way, RICHMOND A1, V6V 2J7. The medical equipment provider can be reached via phone at 604-248-4138 or via email at [email protected]

This page was last updated on 6/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.